Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label Multicentric Phase 1 Study of Selective Cyclin Dependent Kinase Inhibitor P276-00 in Patients With Advanced Refractory Neoplasms

NCT00407498 is registered in ClinicalTrials.gov with Piramal Enterprises Limited as lead sponsor.

NCT NCT00407498
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00407498 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label Multicentric Phase 1 Study of Selective Cyclin Dependent Kinase Inhibitor P276-00 in Patients With Advanced Refractory Neoplasms
Lead sponsor
Piramal Enterprises Limited
Phase
Phase 1
Overall status
Completed
Start date
May 31, 2005
Completion date
September 30, 2008
Enrollment
50 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

neoplasm